Financial News Archive

The company agreed to sell shares of its Common Stock to an investor at a price of $4.80 per share in a private placement transaction....

Perspective Therapeutics and Merck are partnering to evaluate [212Pb]PSV359 combined with Keytruda in solid tumors, potentially reshaping the tumor mi...

Lipocine began its BLOOM Phase 3 trial for LPCN 1154 to support a potential 505(b)(2) NDA, utilizing existing resources despite past data anomalies....

WhiteFiber, Inc. filed an 8-K with an investor presentation, explicitly noting it contains forward-looking statements and cautioning about the risks a...

Larry Ellison has cancelled his 10b5-1 stock sales plan, signaling continued confidence. The departure of a CEO's planned sales often signals bullish ...

Artificial Intelligence Technology Solutions announced the successful integration of its RAD robotics with the Immix monitoring platform, making its R...

Trump Pushes Back on AI Slowdown, Says 'Whoever Wins With AI Wins,' Microsoft CEO Satya Nadella Says Tech Must Stay 'Under Human Control'...

Anthropic Picks Nasdaq for Its $2 Trillion IPO, Tells Investors It Expects a Second Consecutive Profitable Quarter: Reports...

Reported Earlier, Johnson & Johnson Says Rybrevant Plus Chemotherapy Cuts Risk Of Death By 43% Versus Chemotherapy Alone When Adjusted For Crossover I...

'Anthropic Tells Investors It Will Be Profitable For Second Straight Quarter' - FT...

Jim Cramer Calls This Cybersecurity Stock a 'Must Buy' Amid Emerging AI Threats: Here's Why...

Patrick Bet-David Warns Monday Could Be a ‘Bloodbath’ for Stocks as AI Safety Debate Rattles Markets: Samsung, SK Hynix, SoftBank Lead Asian Selloff...

The Information Reported Sunday, Anthropic Signs $13.7B Six-Year Compute Deal With Trump-Linked Rum Group...

Sam Altman Warns AI Race With China Can’t Justify ‘Recklessness’—‘No Reason Any of Us Should Come to Work’ Without Safety Accountability...

Investigating Apple's Standing In Technology Hardware, Storage & Peripherals Industry Compared To Competitors...

Perspective Therapeutics Enters Clinical Trial Collaboration With Merck To Combine Its PSV359 With Keytruda Under An Amendment To Ongoing Phase 1/2A S...

Boeing Executive Says All Flight Testing Has Been Completed For 737 MAX 10, Company Aims To Have It Certified Very Soon...

Trump’s China Car U-Turn? President Says He’d Be ‘Okay’ With Chinese Automakers Building in US...

What's Going On With Nebius Stock on Monday?...

Why Is AMD Stock Falling Monday?...